European Leukemia Trial Registry
Trial: HCT vs CT

More Details
Title HCT Versus CT in Elderly AML
Scientific Title Randomized Phase III Study Comparing Conventional Chemotherapy to Low Dose Total Body Irradiation-Based Conditioning and HCT From Related and Unrelated Donors as Consolidation Therapy for Older Patients With AML in 1st Complete Remission
Short Title HCT vs CT
Trialgroup OSHO
Type of Trial multicentric, randomized, prospective, open-label, double-group
Disease Acute myeloid leukemia(AML) Stem cell transplantation
Age 60-75 years
Status Active
Start of Recruitment 01.10.2012
Leader Niederwieser, Prof. Dr. med. Dr. h.c., Dietger

principal investigator
Niederwieser, Prof. Dr. med. Dr. h.c., Dietger
Tel: +49 (0)341 971 3050
Fax: +49 (0)341 971 3059

Principal Investigator
Löwenberg, Prof. Dr. med, Bob
Tel: +31 (0)10 4087756
Fax: +31 (0)10 4089470

Shortprotocol Shortprotocol
created 29.10.2012 Sina Hehn
changed 01.06.2015 Hanna Ebert
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |